tiprankstipranks
PTC Therapeutics (PTCT)
NASDAQ:PTCT

PTC Therapeutics (PTCT) Stock Investors

303 Followers
Based on 739,015 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PTCT
On average, investors allocate 0.00% of their portfolios to PTCT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 739,015 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PTCT

1.9%
Last 7
Days
0.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PTCT, out of 739,015 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PTCT Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
5.56%
$28.39
Based on the activity of 13,960 investors who made their portfolios public
The table shows changes in PTCT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PTCT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.22%
+0.04%
+2.90%
84.08B
Healthcare
Merck & Company
4.09%
+0.15%
+2.88%
330.96B
Healthcare
Trade Desk
4.73%
-0.52%
+1.25%
46.06B
Technology
Baidu
4.97%
+1.73%
+12.99%
35.15B
Communication Services
Block
4.20%
-0.81%
-1.21%
40.17B
Technology
Applied Materials
4.79%
-0.08%
+6.29%
183.59B
Technology
Zscaler
3.70%
+1.54%
+4.39%
27.12B
Technology
AbbVie
5.57%
-0.95%
+1.37%
299.17B
Healthcare
ServiceNow
3.84%
+1.52%
+4.51%
143.26B
Technology
Raytheon Technologies
4.19%
-1.30%
-0.85%
143.73B
Industrials
Based on the activity of 739,015 active portfolios
Open your Smart Portfolio

PTCT Investor Analysis

PTCT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.9%
of PTCT holders
are under 35
Average Segment Performance
Average P/E Ratio20.54
Beta6.48
Dividend Yield6.25%
PTCT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
45.2%
of PTCT holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.66
Beta11.65
Dividend Yield6.39%
PTCT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
42.9%
of PTCT holders
are over 55
Average Segment Performance
Average P/E Ratio19.45
Beta4.12
Dividend Yield7.17%
Overview of age group and performance of PTCT stock investors
See who invests in PTCT according to age group and performance.

FAQ

How many retail Investors hold PTCT?
<0.1% of TipRanks' retail investors hold PTCT in their portfolios.
    What is PTCT Investor Sentiment?
    PTCT’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of PTCT in the last 7 days?
      ▼ 1.9% of TipRanks' retail investors changed their holding of PTCT in the last 7 days.
        What percentage of retail investors changed their holding of PTCT in the last 30 days?
        ▲ 0.6% of TipRanks' retail investors changed their holding of PTCT in the last 30 days.
          What is the average age of retail investors who hold PTCT?
          The average age of PTCT Holders is between 35–55.
            What other stocks have PTCT investors also bought?
            PTCT Investors also bought BMY, MRK, TTD, BIDU, SQ, AMAT, ZS, ABBV, NOW, RTX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              BDXBecton Dickinson
              CRLCharles River Labs
              CYTKCytokinetics
              DVADaVita
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis